As per the requirement of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Themis Medicare has informed that it enclosed the details of the voting results of the 52nd Annual General Meeting (AGM) of the Company, held on Monday, 19th September, 2022 which commenced at 12.01 pm and concluded at 12.40 pm through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM') as per the prescribed format under the said regulation. Further, consolidated Scrutinizer’s Report on remote e-voting and e-voting at the AGM also enclosed. Consider this as compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.55 |
| Dr. Reddys Lab | 1238.10 |
| Cipla | 1239.20 |
| Zydus Lifesciences | 942.70 |
| Lupin | 2325.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: